Drugs / recombinant FSH
recombinant FSH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01376999 | Apr 2010 → Feb 2014 | infertility disorder | Parc de Salut Mar | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant FSH | “patients started on day 3 of a spontaneous cycle administrating recombinant FSH 75IU sc/day” PMID 35243855 ↗ Nov 2022 |
| Known as | FSH-r | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01376999 ↗ |
| Known as | rFSH | “Significant differences between step-up and step-down protocols were found regarding days of rFSH administration” PMID 35243855 ↗ Nov 2022 |
| Modality | Protein / enzyme biologic | “recombinant FSH 75IU sc/day” PMID 35243855 ↗ Nov 2022 |
| Route | Subcutaneous | “administrating recombinant FSH 75IU sc/day” PMID 35243855 ↗ Nov 2022 |